EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Brain-derived neurotrophic factor in diabetes mellitus: A systematic review and meta-analysis

Fatemeh Moosaie, Soheil Mohammadi, Amene Saghazadeh, Fatemeh Dehghani Firouzabadi, Nima Rezaei iD

PLOS ONE · 14.02.2023 · 18 (2) · e0268816

DOI: 10.1371/journal.pone.0268816 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift PLOS ONE, online erschienen am 14.02.2023. Verfasst von Fatemeh Moosaie und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tehran University of Medical Sciences and Health Services.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Brain-derived neurotrophic factor (BDNF) is a neurotrophic factor expressed in several tissues, including the brain, gut, and pancreas. Activation of the BDNF/TrkB/CREB reduces hepatic gluconeogenesis, induces hepatic insulin signal transduction, and protects against pancreatic beta-cell loss in diabetes mellitus (DM). Several studies have investigated the possible association between BDNF and DM and its complications, but the results have been conflicting.

Aim

In the present study, we aimed at systematically reviewing the literature on the serum and plasma levels of BDNF in DM and its subgroups such as T2DM, DM patients with depression, and patients with retinopathy.

Methods

A comprehensive search was conducted in PubMed, Scopus, and Web of Science. We identified 28 eligible studies and calculated the standardized mean difference (SMD) of outcomes as an effect measure.

Results

The meta-analysis included 2734 patients with DM and 6004 controls. Serum BDNF levels were significantly lower in patients with DM vs. controls (SMD = -1.00, P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic RetinopathyDiabetes Mellitus, Type 2HumansBrain-Derived Neurotrophic FactorTransforming Growth Factor beta

Substanzen

Brain-Derived Neurotrophic FactorTransforming Growth Factor beta

Autor:innen und Institutionen

  • School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Systematic Review and Meta-Analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
  • NeuroImaging Network (NIN), Universal Scientific Education and Research Network (USERN), Tehran University of Medical Sciences, Tehran, Iran.
  • Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
  • MetaCognition Interest Group (MCIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
  • Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Nima Rezaei

Förderung

  • Tehran University of Medical Sciences and Health Services

Zitieren

APA

Moosaie, F., Mohammadi, S., Saghazadeh, A., Dehghani Firouzabadi, F., & Rezaei, N. (2023). Brain-derived neurotrophic factor in diabetes mellitus: A systematic review and meta-analysis. PLOS ONE, 18(2), e0268816. https://doi.org/10.1371/journal.pone.0268816

Vancouver

Moosaie F, Mohammadi S, Saghazadeh A, Dehghani Firouzabadi F, Rezaei N. Brain-derived neurotrophic factor in diabetes mellitus: A systematic review and meta-analysis. PLOS ONE. 2023;18(2):e0268816. doi:10.1371/journal.pone.0268816

BibTeX
@article{Moosaie2023,
  author = {Moosaie, Fatemeh and Mohammadi, Soheil and Saghazadeh, Amene and Dehghani Firouzabadi, Fatemeh and Rezaei, Nima},
  title = {Brain-derived neurotrophic factor in diabetes mellitus: A systematic review and meta-analysis},
  journal = {PLOS ONE},
  year = {2023},
  volume = {18},
  number = {2},
  pages = {e0268816},
  doi = {10.1371/journal.pone.0268816}
}
Kostenlos starten →